Summary: Scientists have identified a conserved genetic program that governs limb regeneration across species. By comparing axolotls, zebrafish, and mice, researchers found that a family of transcription factors, the SP genes (notably SP6 and SP8), acts as a shared regulator for regrowing lost appendages. The study also demonstrates a viral, enhancer-directed gene therapy that can partially restore regenerative capacity in mammals, providing a foundational approach toward one day restoring human limbs.
This research combines comparative genomics, gene editing, and targeted gene delivery to reveal both the molecular basis of regeneration and a proof-of-principle therapy that compensates for missing regenerative signals in mice.
Key findings
- Conserved regenerative program: Regeneration appears to be driven by a shared genetic program rather than unrelated species-specific tricks. That program is active in highly regenerative animals and largely silent or limited in mammals.
- Therapeutic avenue: Beyond prosthetics, bio-scaffolds and stem cells, a gene-therapy strategy that reactivates conserved regenerative pathways offers a complementary route to stimulate the body’s own repair mechanisms.
- Clinical relevance: With more than one million limb amputations worldwide every year from diabetes, trauma and other causes, identifying a molecular target moves the medical field toward biological limb restoration instead of only mechanical replacement.
Source: Wake Forest University
Background and rationale
Researchers from three laboratories, each working on a different model organism, joined forces to compare regeneration programs across species. The team included experts on the Mexican axolotl (a salamander with exceptional regenerative powers), zebrafish (a model with rapid fin and organ regeneration), and mice (a mammalian model that can regenerate digit tips). Their goal was to find molecular features conserved across these diverse systems that could be harnessed to promote regeneration in mammals.
“The project brought three laboratories together to compare regeneration across organisms,” said Josh Currie, an assistant professor of biology who studies axolotl regeneration. “It revealed universal epidermal genetic programs that appear to drive appendage regrowth across these very different animals.”
Why these three species?
- The axolotl can regenerate whole limbs, parts of the spinal cord, and multiple internal organs, making it a gold standard for appendage regeneration.
- Zebrafish rapidly regrow tail fins and other tissues and possess powerful DNA enhancer elements that robustly activate regenerative genes.
- Mice represent mammals and can regrow digit tips when the nailbed is preserved, providing a relevant model for partial mammalian regeneration.
Single-cell RNA sequencing of regenerating zebrafish fins, together with expression data from salamander limbs and mouse digit tips, highlighted the SP family of transcription factors—particularly SP6 and SP8—as conserved, epidermally expressed mediators of appendage regrowth.
Functional tests and therapeutic strategy
The researchers used CRISPR to remove Sp8 in axolotls and observed impaired limb bone regeneration. In mice, conditional loss of Sp6 and/or Sp8 in the basal epidermis disrupted bony digit tip regeneration. These loss-of-function experiments showed that SP factors are required for normal regenerative outcomes.
Building on these findings, the team designed an enhancer-directed gene delivery approach. They used a zebrafish-derived tissue regeneration enhancer to drive expression of FGF8, a secreted growth factor normally regulated by SP factors, delivered by an adeno-associated viral vector. In mice lacking SP genes, targeted FGF8 expression partially rescued digit bone regrowth; in wild-type mice, the same approach accelerated regeneration.
This result establishes a contextual gene-therapy concept: by delivering key downstream effectors under the control of regeneration-specific enhancers, it is possible to substitute for absent or silent upstream regulatory factors and stimulate tissue repair in mammals.
Implications and next steps
While the findings are a foundational advance, translating them to human limb regeneration faces major challenges. A full human limb contains complex, integrated tissues—bone, muscle, nerves, blood vessels, and sensory structures—that must be coordinated during regrowth. The authors emphasize that gene therapy of this type would likely be combined with other technologies, such as bioengineered scaffolds and cell-based approaches, to achieve functional limb restoration.
The collaborative, cross-species design of the study stands out as a model for future regenerative research. Comparing conserved mechanisms across organisms can reveal fundamental controls that individual model systems alone might not disclose.
Frequently asked questions
A: Humans possess the SP genes, but their regenerative program is largely turned off after early development, except in limited contexts such as fingertip regrowth when the nailbed is intact. The study suggests gene therapy could reactivate aspects of the regenerative program by delivering key effectors or enhancers.
A: This is proof-of-principle work in mouse digits. Regrowing a full human limb requires resolving many biological and technical hurdles and likely integrating multiple therapeutic strategies. Significant additional research and safety testing are necessary before clinical application.
A: Zebrafish contribute highly effective DNA enhancer elements—regulatory sequences that strongly activate gene expression during regeneration. The team used one of these enhancers to make the gene therapy active and context-specific in mice.
Editorial notes
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this research
Author: Alicia Roberts
Source: Wake Forest University
Contact: Alicia Roberts – Wake Forest University
Image: Image credit to Neuroscience News
Original research: Open access. “Enhancer-directed gene delivery for digit regeneration based on conserved epidermal factors” by David A. Brown et al., published in Proceedings of the National Academy of Sciences. DOI: 10.1073/pnas.2532804123
Abstract (summary)
Limb loss is a major clinical problem. Regenerative medicine, including gene therapy, offers a strategy to trigger endogenous repair programs, but optimal targets and delivery configurations for appendage repair are not well defined. Leveraging species with high regenerative capacity, the investigators developed an enhancer-directed gene delivery system that functions in the mouse digit regeneration model. Single-cell sequencing and cross-species expression analysis implicated SP family transcription factors as conserved epidermal mediators of appendage regrowth. Loss of Sp8 impaired regeneration in salamanders, and conditional knockout of Sp6 and/or Sp8 in mouse basal epidermis disrupted bony digit tip regeneration. Focused expression of FGF8—a downstream target of SP factors—driven by a zebrafish-derived regeneration enhancer via adeno-associated viral vectors partially rescued digit regeneration in SP knockout mice and accelerated regeneration in wild-type mice. These results support a contextual gene-therapy approach to address limb loss by leveraging conserved epidermal factors.